Skip to main content

Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro

The Original Article was published on 02 December 2021

Correction to: Chinese Medicine (2021) 16: 128 https://doi.org/10.1186/s13020-021-00540-0

Following publication of the original article [1], the authors identified an error in the column DAPI of Fig. 11 (A1). The correct Fig. 11 (Fig. 11) is given in this erratum.

Fig. 11
figure 11

Effect of SZL-containing serum on the expression of dysfunction of CLUTs. Statistical analysis of fluorescence intensity of GLUT1 (A1, A2). Statistical analysis of protein expressions of GLUT1 (B), GLUT3 (D). Statistical analysis of mRNA expression of GLUT1 (C), GLUT3 (E).CG: control group.All data are presented as means ± SEM (n = 6). *P  < 0.05, **P < 0.01 versus Control group, P < 0.05, P < 0.01 versus Model group,  P< 0.05, P < 0.01 versus SZL-containing serum group; one-way ANOVA was used to calculate the p-values

The original article has been corrected.

Reference

  1. Qin G, Dong Y, Liu Z, Gong Z, Gao C, Zheng M, Tian M, He Y, Zhong L, Wang P. Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro. Chin Med. 2021;16:128.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Liqun Zhong or Pengwen Wang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Qin, G., Dong, Y., Liu, Z. et al. Correction to: Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro. Chin Med 16, 144 (2021). https://doi.org/10.1186/s13020-021-00551-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13020-021-00551-x